Advertise Content Page.

Thank you for considering us for your advertising needs. We are proud of the high quality content we are able to share with our readers. Our advertisers give us the ability to stay online and are very important to us.

If you have any type of Headache related service or product, we can help.

Available Advertising Opportunities:

Featured Text Link

Available Spots: 4

Current Advertisers:1

Featured Website Image Link

Available Spots: 3

Current Advertisers: 2

Article Sponsorship

Available Spots: 2

Current Advertisers: 0


Headache Related Articles:

About Headaches

For many people, a headache is an infrequent annoyance that disappears after swallowing a few tablets. But for chronic headache sufferers, the effects can be far worse. The World Headache Alliance has fourteen different cl...

By: Schmell Kopfs

Dihydroergotamine and Ergotamine

Description Dihydroergotamine and ergotamine belong to the group of medicines known as ergot alkaloids. They are used to treat severe, throbbing headaches, such as migraine and clus...

By: Matthias C.

Tension Headache, Fioricet and Butalbital

At our online pharmacy and many others, the most frequently prescribed medication is butalbital, the generic form of Fioricet. Patients are prescribed this medication for relief of ten...

By: David Altfeder

Updated Migraine headaches Related News:

Doctors Discover One Migraine Solution (CBS4 Miami)

More than 29 million Americans suffer from migraine headaches, and they affect women three times more than men.  These  debilitating headaches strike those between the ages of 15 and 55.  A London...


Migraine Mutations Reveal Clues To Biological Basis Of Disorder (Medical News...

Fifteen percent to 20 percent of people worldwide suffer from migraines excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, resear...


NuPathe says results good for migraine skin patch (Philly.com)

NuPathe Inc., a privately held specialty pharmaceutical company developing treatments and technologies for neurologic and psychiatric disorders, announced today that it had received positive Phase I r...



Website Friends: